Robert Wasserman
Stock Analyst at Benchmark Co.
(4.32)
# 1,403
Out of 4,696 analysts
231
Total ratings
46.8%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLFS BioLife Solutions | Downgraded: Hold | n/a | $35.92 | - | 11 | Aug 10, 2026 | |
| TLV: KMDA Kamada Ltd. | Maintained: Buy | ILA 4,535 | ILA 2,461 | +84.29% | 5 | Jul 20, 2026 | |
| LGND Ligand Pharmaceuticals | Maintained: Buy | $220 → $335 | $286.92 | +16.76% | 20 | Jul 16, 2026 | |
| RGEN Repligen | Upgraded: Buy | $185 | $172.94 | +6.97% | 11 | Jul 7, 2026 | |
| PRLB Proto Labs | Maintained: Buy | $91 | $78.59 | +15.79% | 16 | Jul 6, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | n/a | $72.30 | - | 18 | Jun 30, 2026 | |
| ITGR Integer Holdings | Upgraded: Buy | $140 → $95 | $125.31 | -24.19% | 18 | Feb 20, 2026 | |
| HALO Halozyme Therapeutics | Maintained: Buy | $90 | $109.66 | -17.93% | 22 | Feb 19, 2026 | |
| CDXS Codexis | Maintained: Hold | n/a | $1.48 | - | 16 | Nov 14, 2025 | |
| OABI OmniAb | Maintained: Buy | $6 → $4 | $5.04 | -20.63% | 11 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $4.00 | +837.50% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $11.36 | n/a | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $4.22 | n/a | 8 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $6.46 | n/a | 20 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.34 | n/a | 8 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $4.52 | n/a | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $608.54 | n/a | 7 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $209.91 | n/a | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.15 | n/a | 4 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $80 | $2.10 | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.73 | n/a | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.65 | n/a | 3 | Jan 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $4.11 | n/a | 1 | Jan 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4.2 | $6.98 | n/a | 1 | Oct 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $0.739 | n/a | 1 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.14 | n/a | 2 | Jan 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.25 | $0.9659 | n/a | 1 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $8.09 | n/a | 1 | Mar 12, 2013 |
BioLife Solutions
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $35.92
Upside: -
Kamada Ltd.
Jul 20, 2026
Maintained: Buy
Price Target: ILA 4,535
Current: ILA 2,461
Upside: +84.29%
Ligand Pharmaceuticals
Jul 16, 2026
Maintained: Buy
Price Target: $220 → $335
Current: $286.92
Upside: +16.76%
Repligen
Jul 7, 2026
Upgraded: Buy
Price Target: $185
Current: $172.94
Upside: +6.97%
Proto Labs
Jul 6, 2026
Maintained: Buy
Price Target: $91
Current: $78.59
Upside: +15.79%
Bio-Techne
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $72.30
Upside: -
Integer Holdings
Feb 20, 2026
Upgraded: Buy
Price Target: $140 → $95
Current: $125.31
Upside: -24.19%
Halozyme Therapeutics
Feb 19, 2026
Maintained: Buy
Price Target: $90
Current: $109.66
Upside: -17.93%
Codexis
Nov 14, 2025
Maintained: Hold
Price Target: n/a
Current: $1.48
Upside: -
OmniAb
Nov 6, 2025
Maintained: Buy
Price Target: $6 → $4
Current: $5.04
Upside: -20.63%
Oct 31, 2025
Maintained: Buy
Price Target: $38
Current: $4.00
Upside: +837.50%
Aug 13, 2025
Maintained: Hold
Price Target: n/a
Current: $11.36
Upside: n/a
Aug 12, 2025
Maintained: Buy
Price Target: $5
Current: $4.22
Upside: n/a
Aug 8, 2025
Maintained: Buy
Price Target: $12
Current: $6.46
Upside: n/a
Jul 31, 2025
Maintained: Buy
Price Target: $3
Current: $1.34
Upside: n/a
Feb 3, 2025
Downgraded: Hold
Price Target: $4
Current: $4.52
Upside: n/a
Oct 26, 2023
Maintained: Hold
Price Target: n/a
Current: $608.54
Upside: n/a
Oct 25, 2023
Maintained: Hold
Price Target: n/a
Current: $209.91
Upside: n/a
Sep 15, 2023
Maintained: Hold
Price Target: n/a
Current: $5.15
Upside: n/a
Apr 4, 2023
Maintained: Buy
Price Target: $9 → $80
Current: $2.10
Upside: n/a
Feb 24, 2021
Reiterated: Buy
Price Target: $9
Current: $2.73
Upside: n/a
Jan 24, 2020
Rated: Hold
Price Target: n/a
Current: $1.65
Upside: n/a
Jan 9, 2019
Initiated Coverage: Buy
Price Target: $11
Current: $4.11
Upside: n/a
Oct 17, 2018
Initiated Coverage: Buy
Price Target: $4.2
Current: $6.98
Upside: n/a
Aug 28, 2018
Initiated Coverage: Buy
Price Target: $46
Current: $0.739
Upside: n/a
Jan 29, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $2.14
Upside: n/a
Nov 7, 2013
Initiated Coverage: Buy
Price Target: $5.25
Current: $0.9659
Upside: n/a
Mar 12, 2013
Reiterated: Buy
Price Target: $6
Current: $8.09
Upside: n/a